Advertisement
Screener

Plante Moran Financial Advisors, LLC Historic Quarter Change: Foreign ADRs, Reduced

Plante Moran Financial Advisors, LLC historic quarter change: Foreign ADRs, Reduced

In depositary receipts for foreign shares (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, Plante Moran Financial Advisors, LLC opened 39 positions, added to 39, reduced 29 and sold out of 40.

  • Q1 2025: Stock TOTALENERGIES SE SPONSORED ADS; Country of operation —; Class ADR; Shares before 665.
  • Q3 2016: Stock GlaxoSmithKline PLC ADR; Country of operation —; Class ADR; Shares before 1,746.
  • Q3 2016: Stock Royal Dutch Shell PLC ADR Clas; Country of operation —; Class ADR; Shares before 1,584.
  • Q2 2016: Stock AstraZeneca PLC ADR; Country of operation —; Class ADR; Shares before 2,367.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1424717), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-06); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-05); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-05); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-05); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-08-05); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-08); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-05); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-30); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-12); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-09); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-03); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-03); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-26); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-01); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-03); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-22); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-24); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-27); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-23); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-28); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-21); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-21); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-23). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2008-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q1 2025TOTALENERGIES SE SPONSORED ADS
CUSIP 89151E109
ADR665480-185$36,243$31,051-$5,1922025-05-08
Q3 2016GlaxoSmithKline PLC ADR
CUSIP 37733W105
ADR1,746790-956$76,000$34,000-$42,0002016-11-03
Q3 2016Royal Dutch Shell PLC ADR Clas
CUSIP 780259206
ADR1,5841,213-371$87,000$61,000-$26,0002016-11-03
Q2 2016AstraZeneca PLC ADR
CUSIP 046353108
ADR2,3671,700-667$67,000$51,000-$16,0002016-08-03
Q1 2016GlaxoSmithKline PLC ADR
CUSIP 37733W105
ADR2,5571,700-857$103,000$69,000-$34,0002016-04-26
Q1 2016Unilever NV ADR
CUSIP 904784709
ADR61348-565$27,000$2,000-$25,0002016-04-26
Q1 2016National Grid PLC ADR
CUSIP 636274300
ADR37924-355$26,000$2,000-$24,0002016-04-26
Q1 2016Royal Dutch Shell PLC ADR Clas
CUSIP 780259107
ADR48547-438$22,000$2,000-$20,0002016-04-26
Q1 2016ARM Holdings PLC ADR
CUSIP 042068106
ADR30045-255$14,000$2,000-$12,0002016-04-26
Q1 2016Total SA ADR
CUSIP 89151E109
ADR1,9741,927-47$89,000$88,000-$1,0002016-04-26
Q4 2015Royal Dutch Shell PLC ADR Clas
CUSIP 780259206
ADR1,5761,442-134$75,000$66,000-$9,0002016-02-01
Q4 2015Alcatel-Lucent ADR
CUSIP 013904305
ADR4763-473$2,000$0-$2,0002016-02-01
Q2 2015AstraZeneca PLC ADR
CUSIP 046353108
ADR1,2161,152-64$83,000$73,000-$10,0002015-07-22
Q2 2015Total SA ADR
CUSIP 89151E109
ADR2,0351,927-108$101,000$95,000-$6,0002015-07-22
Q2 2015ARM Holdings PLC ADR
CUSIP 042068106
ADR172142-30$8,000$7,000-$1,0002015-07-22
Q1 2015AstraZeneca PLC ADR
CUSIP 046353108
ADR1,3461,216-130$95,000$83,000-$12,0002015-04-24
Q1 2015Royal Dutch Shell PLC ADR Clas
CUSIP 780259107
ADR128100-28$9,000$6,000-$3,0002015-04-24
Q1 2015GlaxoSmithKline PLC ADR
CUSIP 37733W105
ADR753700-53$32,000$32,000$02015-04-24
Q4 2014Glaxosmithkline PLC
CUSIP 37733W105
ADR1,870753-1,117$86,000$32,000-$54,0002015-01-27
Q4 2014Royal Dutch Shell PLC Class A
CUSIP 780259206
ADR670648-22$51,000$43,000-$8,0002015-01-27
Q3 2014Total SA
CUSIP 89151E109
ADR36130-331$26,000$2,000-$24,0002014-10-23
Q3 2014Royal Dutch Shell PLC Cl B
CUSIP 780259107
ADR113100-13$10,000$8,000-$2,0002014-10-23
Q1 2014Glaxosmithkline PLC ADR
CUSIP 37733W105
ADR952700-252$51,000$37,000-$14,0002014-04-21
Q1 2014Alcatel-Lucent Sponsored ADR
CUSIP 013904305
ADR213-18$0$0$02014-04-21
Q4 2013Glaxosmithkline PLC ADR
CUSIP 37733W105
ADR2,146952-1,194$108,000$51,000-$57,0002014-01-21
Q4 2013Total ADR
CUSIP 89151E109
ADR89092-798$52,000$6,000-$46,0002014-01-21
Q4 2013CRH Plc ADR
CUSIP 12626K203
ADR500186-314$12,000$5,000-$7,0002014-01-21
Q4 2013Arm Holdings
CUSIP 042068106
ADR10630-76$5,000$2,000-$3,0002014-01-21
Q3 2013Alcatel-Lucent Sponsored ADR
CUSIP 013904305
ADR2321-2$0$0$02013-10-23

Similar Firms

Firm NameCountry13F ValueHoldings
FIFTH THIRD SECURITIES, INC.United States$1.546B341
NICHOLS & PRATT ADVISERS LLP /MAUnited States$1.549B188
Charles Schwab Trust CoUnited States$1.542B165
ALBION FINANCIAL GROUP /UTUnited States$1.550B737
ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/United States$1.551B1,550
Bristol Gate Capital Partners Inc.Canada$1.552B31
Icon Wealth Advisors, LLCUnited States$1.540B389
MUFG SECURITIES AMERICAS INC.United States$1.552B504
Boston Common Asset Management, LLCUnited States$1.553B186
VALLEY WEALTH MANAGERS, INC.United States$1.553B504